Label-Free Drug Discovery Market, Global Outlook and Forecast 2023-2030
In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which new candidate medications are discovered. Drug Discovery Service are specifically designed to minimize the costs and timelines of drug discovery.Skipping the tedious labeling and optimization steps required by other drug screening technologies, the label-free method eliminates the long time, higher cost and false positive results required by traditional detection methods.
This report aims to provide a comprehensive presentation of the global market for Label-Free Drug Discovery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Label-Free Drug Discovery. This report contains market size and forecasts of Label-Free Drug Discovery in global, including the following market information:
Global Label-Free Drug Discovery Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Label-Free Drug Discovery market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Cellular Dielectric Spectroscopy Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Label-Free Drug Discovery include Thermo Fisher Scientific, GE Healthcare, Corning, Albany Molecular Research, Inc (AMRI), Charles River Laboratories, Evotec, Jubilant Biosys, WuXi AppTec and Agilent, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Label-Free Drug Discovery companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Label-Free Drug Discovery Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Label-Free Drug Discovery Market Segment Percentages, by Type, 2022 (%)
Cellular Dielectric Spectroscopy
Bio-layer Interferometry
Surface Plasmon Resonance
Optical Waveguide Grating Technology
Global Label-Free Drug Discovery Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Label-Free Drug Discovery Market Segment Percentages, by Application, 2022 (%)
Pharmaceutical Companies
Research Laboratories
Other
Global Label-Free Drug Discovery Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Label-Free Drug Discovery Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Label-Free Drug Discovery revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Label-Free Drug Discovery revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Thermo Fisher Scientific
GE Healthcare
Corning
Albany Molecular Research, Inc (AMRI)
Charles River Laboratories
Evotec
Jubilant Biosys
WuXi AppTec
Agilent
SAMDI Tech
Outline of Major Chapters:
Chapter 1: Introduces the definition of Label-Free Drug Discovery, market overview.
Chapter 2: Global Label-Free Drug Discovery market size in revenue.
Chapter 3: Detailed analysis of Label-Free Drug Discovery company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Label-Free Drug Discovery in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
